In contrast, VISTA, an alternative immune checkpoint receptor, is preferentially expressed in epithelioid mesotheliomas [31,33] where it may mediate immune evasion in these typically PD-L1-low tumors [11]. The gene discussed is CD274; the disease is malignant epithelioid mesothelioma.